EMCDDA, Lisbon, May 2020
Summary
This 2020 EMCDDA update on drug-related infectious diseases aims to provide a comprehensive overview of the current situation with regard to the epidemiological picture of drug-related infectious diseases in Europe up to January 2020, while highlighting some of the current innovative responses to the problem.
Table of contents
- At a glance
- Introduction
- European overview of HIV trends and prevalence among people who inject drugs
- HIV continuum of care among people who inject drugs: European countries lag behind treatment and viral suppression targets
- European overview of viral hepatitis prevalence among people who inject drugs
- Viral hepatitis: the EMCDDA elimination barometer supports national monitoring
- Local outbreaks of infectious diseases among people who inject drugs
- Promoting evidence-based interventions
- References
- Acknowledgements
Main subject:
Follow this news feed: EU